Search
Subscribe
Latest Stories
Business
Legal
Pipeline
Research
Events
Products
Clinical Articles
Ocular Surface
Contact Lenses
Glaucoma
Retina
Pediatrics
SEE MORE »
Jobs
Optometrist Jobs
Ophthalmologist Jobs
Optician & Technician Jobs
Hiring Services for Employers
SEE ALL JOBS »
Virtual Events
Upcoming Events
Clinical Trials
Stories
Business
Legal
Pipeline
Research
Events
Products
Archives
See All Stories
Resources
Reports
Cheat Sheets
Ultimate Guides
Calculators & Tools
See All Resources
Events
Courses
Jobs
Search Eyecare Jobs
Hiring Services for Employers
Published Date
Clear
Start Date
End Date
Category
Pipeline
1
Organizations
Bausch + Lomb
67
Eyes On Eyecare
53
Alcon, Inc.
47
American Optometric Association
38
Harrow
31
Glaukos
28
Topcon Healthcare
25
Regeneron
24
Aldeyra Therapeutics
21
Sight Sciences
19
Tags
FDA
1
Retina
1
Retinopathy Of Prematurity
1
Organizations:
SignaBlok
✕
Clear all
Pipeline
FDA grants Orphan Drug Designation to SignaBlok's ROP therapy
TREM-1 inhibitor is designed to selectively target inflammation via a noninvasive delivery; company plans to report preclinical data at ARVO annual meeting.
